ATHA insider transactions

CHIEF MEDICAL OFFICER San Martin Javier converted options into 4,667 shares and sold $11,311 worth of shares (1,644 units at $6.88), increasing direct ownership by 42% to 10,189 units (SEC Form 4)

President and CEO Litton Mark James sold $17,792 worth of shares (2,586 units at $6.88) and converted options into 10,834 shares, increasing direct ownership by 25% to 40,828 units (SEC Form 4)

Chief Financial Officer Renninger Robert was granted 1,000 shares, converted options into 1,236 shares and sold $2,043 worth of shares (297 units at $6.88), increasing direct ownership by 18% to 12,857 units (SEC Form 4)

CHIEF SCIENTIFIC OFFICER Church Kevin was granted 1,000 shares, converted options into 3,667 shares and sold $6,027 worth of shares (876 units at $6.88), increasing direct ownership by 22% to 20,681 units (SEC Form 4)

General Counsel and CCO Worthington Mark converted options into 3,667 shares and sold $6,027 worth of shares (876 units at $6.88), increasing direct ownership by 25% to 13,978 units (SEC Form 4)

SEC Form 4 filed by Chief Financial Officer Renninger Robert

SEC Form 4 filed by President and CEO Litton Mark James

SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Church Kevin

SEC Form 4 filed by CHIEF MEDICAL OFFICER San Martin Javier

SEC Form 4 filed by General Counsel and CCO Worthington Mark

Director Perceptive Advisors Llc was granted 1,319,026 shares (SEC Form 4)

CHIEF SCIENTIFIC OFFICER Church Kevin was granted 10,000 shares, converted options into 36,666 shares and sold $2,502 worth of shares (8,526 units at $0.29), increasing direct ownership by 29% to 168,901 units (SEC Form 4)

President and CEO Litton Mark James converted options into 108,334 shares and sold $7,374 worth of shares (25,123 units at $0.29), increasing direct ownership by 34% to 325,802 units (SEC Form 4)

CHIEF MEDICAL OFFICER San Martin Javier converted options into 46,666 shares and sold $3,182 worth of shares (10,842 units at $0.29), increasing direct ownership by 100% to 71,665 units (SEC Form 4)

General Counsel and CCO Worthington Mark converted options into 36,666 shares and sold $2,502 worth of shares (8,526 units at $0.29), increasing direct ownership by 34% to 111,875 units (SEC Form 4)

SVP, Finance and Accounting Renninger Robert converted options into 12,359 shares, sold $850 worth of shares (2,897 units at $0.29) and was granted 10,000 shares, increasing direct ownership by 22% to 109,186 units (SEC Form 4)

SEC Form 4 filed by Director Fluke John M Jr

SEC Form 4 filed by Director Panzara Michael A.

SEC Form 4 filed by Director Romano Kelly A

SEC Form 4 filed by Director Edelman Joseph

SEC Form 4 filed by Director Johnson James A

SEC Form 4 filed by Director Kosacz Barbara

SEC Form 4 filed by Director Pickering Grant

Amendment: SEC Form 4 filed by SVP, Finance and Accounting Renninger Robert

SEC Form 4 filed by SVP, Finance and Accounting Renninger Robert

SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Church Kevin

SEC Form 4 filed by President and CEO Litton Mark James

SEC Form 4 filed by CHIEF MEDICAL OFFICER San Martin Javier

SEC Form 4 filed by General Counsel and CCO Worthington Mark

CHIEF MEDICAL OFFICER San Martin Javier converted options into 46,667 shares and sold $6,083 worth of shares (10,826 units at $0.56) (SEC Form 4)

President and CEO Litton Mark James converted options into 108,333 shares and sold $14,108 worth of shares (25,107 units at $0.56), increasing direct ownership by 52% to 242,591 units (SEC Form 4)

CHIEF SCIENTIFIC OFFICER Church Kevin was granted 9,920 shares, converted options into 36,667 shares and sold $4,782 worth of shares (8,510 units at $0.56), increasing direct ownership by 41% to 130,761 units (SEC Form 4)

VP of Finance Renninger Robert was granted 3,651 shares, converted options into 12,359 shares and sold $1,619 worth of shares (2,881 units at $0.56), increasing direct ownership by 17% to 89,724 units (SEC Form 4)

General Counsel and CCO Worthington Mark was granted 3,651 shares, converted options into 36,667 shares and sold $4,782 worth of shares (8,510 units at $0.56), increasing direct ownership by 61% to 83,735 units (SEC Form 4)

Amendment: SEC Form 4 filed by President and CEO Litton Mark James

SEC Form 4 filed by VP of Finance Renninger Robert

SEC Form 4 filed by CHIEF MEDICAL OFFICER San Martin Javier

SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Church Kevin

SEC Form 4 filed by General Counsel and CCO Worthington Mark

SEC Form 4 filed by President and CEO Litton Mark James

New insider Renninger Robert claimed ownership of 76,595 shares (SEC Form 3)

CFO and Chief Business Officer Gengos Andrew was granted 15,000 shares and sold $720 worth of shares (1,272 units at $0.57), increasing direct ownership by 16% to 97,532 units (SEC Form 4)

COO and CDO Lenington Rachel was granted 10,000 shares and sold $1,429 worth of shares (2,525 units at $0.57), increasing direct ownership by 56% to 20,870 units (SEC Form 4)

CHIEF SCIENTIFIC OFFICER Church Kevin was granted 14,953 shares and sold $1,429 worth of shares (2,525 units at $0.57), increasing direct ownership by 15% to 92,684 units (SEC Form 4)

GENERAL COUNSEL Worthington Mark was granted 20,000 shares and sold $1,429 worth of shares (2,525 units at $0.57), increasing direct ownership by 51% to 51,927 units (SEC Form 4)

President and CEO Litton Mark James was granted 20,000 shares and sold $2,848 worth of shares (5,032 units at $0.57), increasing direct ownership by 10% to 159,365 units (SEC Form 4)

Director Romano Kelly A bought $100,051 worth of shares (42,400 units at $2.36), increasing direct ownership by 111% to 80,715 units (SEC Form 4)

SEC Form 4 filed by Romano Kelly A

SEC Form 4 filed by Edelman Joseph

SEC Form 4 filed by Johnson James A

SEC Form 4 filed by Kosacz Barbara

SEC Form 4 filed by Panzara Michael A.

SEC Form 4 filed by Pickering Grant

SEC Form 4 filed by Fluke John M Jr

SEC Form 4 filed by San Martin Javier

SEC Form 3 filed by new insider San Martin Javier

SEC Form 4 filed by Litton Mark James

SEC Form 4 filed by Worthington Mark

SEC Form 4 filed by Church Kevin

SEC Form 4 filed by Gengos Andrew